Parkwalk Advisors

Great news from portfolio company Intelligent Ultrasound, which today announced the proposed sale of its Clinical AI business to GE HealthCare for £40.5m. Achieving a premium of >70% to its closing share price yesterday for that business unit alone, is a great outcome for the company. Furthermore, Intelligent Ultrasound will retain its simulation business, which generated total revenues of £10m in 2023. Intelligent Ultrasound also noted that it intends to make a material return of capital following a review of the growth potential and capital requirements of the post-transaction business. As significant shareholders in the business, along with our parent company IP Group plc, we are pleased to share such positive news for the company. #Ultrasound #InvestinginInnovation #MedTech

🚨 Portfolio announcement 🚨 We are delighted to announce the acquisition of portfolio company Versed AI by US supply chain and third-party risk AI company Exiger, resulting in a positive exit for Parkwalk investors. Versed AI’s artificial intelligence technology accelerates the process of extracting and aggregating multi-tier supplier networks, creating automated bills of material and generating proprietary value chain graph data. The integration of Versed AI into Exiger’s award-winning supply chain management platform will allow customers to rapidly expand multi-tier visibility with access to unrivaled advancements in supply chain tracing, orchestration and mapping. Find out more about the acquisition here: https://rebrand.ly/1yq62kk Find out more about Parkwalk's funds here: https://rebrand.ly/g8rouq9

📣 Exciting news for portfolio company and University of Oxford spin-out Moa Technology who have today announced a research and commercial partnership with Nufarm, a global agricultural innovator based in Melbourne, Australia. 👏 The deal provides Nufarm with exclusive access to one of Moa's promising new herbicide modes of action, discovered via its breakthrough innovation platform and currently in field trials in the US, UK, France and Spain. Moa in turn will receive upfront payments, milestone development payments and eventual royalties from sales of the herbicide, which could be the first broad spectrum agricultural herbicide to work in a completely different way in forty years.  We're very much looking forward to following their progress! Find out more about the partnership here: https://rebrand.ly/tkpx1gz Find out more about Parkwalk and our funds here: https://rebrand.ly/g8rouq9 #InvestinginInnovation #agtech #EIS

Since our inception in 2009, Parkwalk Advisors has been on an incredible journey, only made possible by the vision of our co-founders. With 180 companies supported, 1000s of jobs created, and a huge impact on society, we wanted to say a huge thank you to our co-founder Alastair Kilgour for everything he has done for Parkwalk and the wider venture capital & university spin-out community. We wish you well for your next (well-earned!) chapter and are pleased you will still be part of the Parkwalk family through various NED roles in our portfolio companies. 

🏆 Delighted to sponsor the award for #bestfinancialplanner at last night's EISA Awards at the UK House of Lords. Congratulations to Andrew Elson - 👉 Helping you maximise retirement 👈 of Berry & Oak (represented by son Connor) and to all of the other award winners. 🎉 A huge thank you to the Enterprise Investment Scheme Association (EISA) and particularly Christiana Stewart-Lockhart, Olivia Wing and Mary Rodgers for an enjoyable evening as always! #investingininnovation #EIS #enterpriseinvestmentscheme

🚨 Funding round announcement 🚨 Delighted to announce our investment into DeepForm as part of a £2m funding round, alongside Cambridge Enterprise.   Spun-out of the University of Cambridge, DeepForm’s novel solution can reduce material waste in car manufacturing by over 75%, as well as helping manufacturers reduce CO2 emissions. DeepForm’s solution uses novel 3-D gripping technology and has already been used in carbon reduction studies with six OEMs, reducing trimming scrap by almost 40% in some cases!   Moray Wright, Chief Executive at Parkwalk Advisors, said: “Automobile manufacturers around the world have committed to reach net zero both from tailpipe emissions and manufacturing. DeepForm’s technology has the potential to reduce wastage and emissions from vehicle production, and has wide ranging commercial applications. We are thrilled to have led DeepForm’s first funding round – a great testament of our commitment to help fund revolutionary ideas from UK universities.”   Read the full press release here: https://lnkd.in/eaQr_xrH   Chris Cleaver DeepForm   #InvestinginInnovation #automotiveindustry #materialefficiency

Honoured to attend the recent inaugural U.S.-U.K. Strategic Technologies Investor Council (STIC) meeting at the White House. This innovative event, co-chaired by U.K. National Security Advisor Sir Tim Barrow and U.S. National Security Advisor Jake Sullivan, marks a significant milestone in the 2023 Atlantic Declaration, aimed at strengthening our alliance across defence, science, health security, and space.   Parkwalk Advisors is extremely proud to support emerging technologies in these critical areas. The collaborative international approach facilitated by the STIC is crucial for both the U.S. and the U.K. to maintain leadership in the development and acceleration of technologies vital to national security and beyond.   A big thank you to the UK's Department for Science, Innovation and Technology and HM Treasury for organising this event and driving this essential initiative forward. These efforts make a great contribution to ensuring that strategic technological advancements can thrive on both sides of the Atlantic.

Brilliant to see Imperial College London climbing to 2nd place in the 2025 QS World University Rankings last week!👏 We’re proud to invest in Imperial spin-outs across a range of sectors, including 🧬 Life Sciences, ⚡Quantum Computing, 🌍 Clean-Tech & 🩺 Digital Health. Backing the next generation of science and technology companies incubated in the Imperial ecosystem, investors in our Imperial College Enterprise Funds can also benefit from tax reliefs under the Enterprise Investment Scheme*. 🚨 Our third Imperial College Enterprise Fund closes to new investment at the end of June. 🚨 Read more about Imperial’s achievement in the Financial Times here: https://rebrand.ly/skq9zcx Find out more about the Fund here: https://rebrand.ly/mnjwnm2 or contact [email protected]. 👈 #ImperialCollege #InvestinginInnovation #Technology *Personal tax circumstances may differ. See our Information Memorandum for further information. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more: https://rebrand.ly/r504e7k. Parkwalk Advisors is authorised and regulated by the Financial Conduct Authority: 502237. Past performance may not be repeated and is not indicative of future results. June 2024.

Funding round announcement 🚨 Delighted to announce our latest investment into Psyomics, as part of a £4m funding round. Psyomics is revolutionising mental health care with its AI-informed medical device Censeo, which is already helping clinicians at several NHS Trusts to help reduce waiting times and administrative burdens in mental health services. 📣 The funding will be used to expand Censeo to include specialist mental health assessments for children and young people 📣 Developed in collaboration with leading neurotechnology and clinical experts from the University of Cambridge, Censeo is designed to improve the assessment and triage of mental health conditions 📣 Psyomics also announces exclusive international license on world first biomarker for identifying bipolar disorder Psyomics CEO, Dr Melinda Rees emphasises the critical need for timely mental health support, especially in the wake of Covid, which has seen an alarming downturn in children's mental health. Supporting children and young people through more streamlined mental health assessments is crucial for gaining access to the right treatment sooner. Parkwalk’s Investment Director, Martin Glen, highlights the growing demand for mental health services and how Psyomics' innovative technology is set to transform mental health assessment both in the UK and globally. Find out more about our latest investment here: https://lnkd.in/eHDucnbH #InvestinginInnovation #MentalHealth #HealthTech #Psyomics #Investment #HealthcareInnovation #MentalHealthAwareness